• Monday,October 07,2024
ururembotoursandtravel.com
X

Frontiers Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice

$ 14.50

4.5 (723) In stock

Share

New therapeutic targets in Alzheimer's disease: brain deregulation

Mechanism of psychoactive substance-induced cognitive disorders

Lack of Tau Proteins Rescues Neuronal Cell Death and Decreases Amyloidogenic Processing of APP in APP/PS1 Mice - ScienceDirect

/files/Articles/841942/fnagi-14

Frontiers Plaque-Associated Oligomeric Amyloid-Beta Drives Early

Co-pathologies and Other Modifiers of Tau Aggregation and Spread

Locomotor Hyperactivity in the Early-Stage Alzheimer's Disease

Frontiers Morphological and biomolecular targets in retina and

MicroRNA-98 reduces amyloid β-protein production and improves

Frontiers Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation

Aging modulates microglia phenotypes in neuroinflammation of MPTP

Immune-mediated platelet depletion augments Alzheimer's disease

Frontiers Plaque-Associated Oligomeric Amyloid-Beta Drives Early

MicroRNA-98 reduces amyloid β-protein production and improves